01 3Gowlings
02 3Blank
01 11284501
02 11302853
03 11307003
04 32315784
01 1RIVASTIGMINE
02 2Rivastigmine
03 3Blank
01 1PATCH
02 2Patch
03 3Blank
01 12008-05-28
02 22009-09-01
03 32019-01-08
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Brand Name : EXELON PATCH 5
Patent Number : 2315784
Filing Date : 1999-01-08
Strength per Unit : 9.0mg / 5cm
Dosage Form : Patch
Human Or VET : Human
Route of Administration : Transdermal
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Brand Name : EXELON PATCH 10
Patent Number : 2315784
Filing Date : 1999-01-08
Strength per Unit : 18.0mg / 10cm
Dosage Form : Patch
Human Or VET : Human
Route of Administration : Transdermal
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Brand Name : EXELON PATCH 15
Patent Number : 2315784
Filing Date : 1999-01-08
Strength per Unit : 27.0 mg / 15 cm
Dosage Form : PATCH
Human Or VET : Human
Route of Administration : TRANSDERMAL
Patent Expiration Date : 2019-01-08
Date Granted : 2006-06-27
Patent Expiration Date : 2008-05-28
Date Granted :
Brand Name :
Patent Number : 1284501
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2008-05-28
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2009-09-01
Date Granted :
Brand Name :
Patent Number : 1302853
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-09-01
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2009-09-01
Date Granted :
Brand Name :
Patent Number : 1307003
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2009-09-01
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
